Aimfinity Seeks SPAC Extension, NTA Waiver for Docter Merger
Ticker: AIMTF · Form: DEF 14A · Filed: Oct 14, 2025 · CIK: 1903464
Sentiment: mixed
Topics: SPAC, Merger Extension, Shareholder Vote, DEF 14A, Business Combination, Redemption Rights, Net Tangible Assets
Related Tickers: AIMTF, AIMUF, AIMWF, AIMBU, AIMAU
TL;DR
**AIMTF needs these proposals passed to avoid liquidation and close the Docter deal; vote YES or risk losing your investment in this SPAC.**
AI Summary
Aimfinity Investment Corp. I (AIMTF) is seeking shareholder approval for two key proposals at an Extraordinary General Meeting on October 27, 2025, to facilitate its business combination with Docter Inc. The first, the Charter Amendment Proposal, aims to extend the deadline for completing a business combination from October 28, 2025, to July 28, 2026, through up to nine one-month extensions, each requiring a $500 deposit by the Sponsor into the Trust Account. The second, the NTA Requirement Amendment Proposal, seeks to eliminate the existing charter limitation that prevents redemptions if the company's net tangible assets fall below $5,000,001. Shareholders previously approved the Docter Business Combination on March 27, 2025, with 1,072,957 New Units tendered for redemption. Approval of both proposals would grant the company greater flexibility to close the Docter Business Combination, while failure to approve the Charter Amendment could lead to liquidation by October 28, 2025.
Why It Matters
This filing is critical for AIMTF investors as it directly impacts the viability of the Docter Inc. business combination. Approval of the Charter Amendment provides a crucial nine-month extension, preventing immediate liquidation and offering more time to finalize the deal. The NTA Requirement Amendment is equally significant, as its approval removes a potential hurdle that could otherwise block the merger if redemptions cause net tangible assets to drop below $5,000,001, thereby protecting the transaction's closing. For employees and customers of Docter Inc., the successful completion of this SPAC merger means continued business operations and potential growth under a public entity, while failure could lead to uncertainty and a return of funds to AIMTF shareholders, leaving Docter without its SPAC partner.
Risk Assessment
Risk Level: high — The risk level is high because failure to approve the Charter Amendment Proposal by October 28, 2025, will result in the company ceasing operations and liquidating its Trust Account. Additionally, if the NTA Requirement Amendment Proposal is not approved, the company may be unable to consummate the Docter Business Combination if redemptions cause net tangible assets to fall below $5,000,001, leading to potential liquidation.
Analyst Insight
Investors should carefully consider voting 'FOR' both the Charter Amendment Proposal and the NTA Requirement Amendment Proposal to maximize the likelihood of the Docter Business Combination closing. Failure to approve these could lead to the liquidation of Aimfinity Investment Corp. I, returning cash to shareholders but eliminating the potential upside of the merger.
Financial Highlights
- debt To Equity
- 0.0
- revenue
- $0
- operating Margin
- 0%
- total Assets
- $0
- total Debt
- $0
- net Income
- $0
- eps
- $0
- gross Margin
- 0%
- cash Position
- $0
- revenue Growth
- N/A
Key Numbers
- October 28, 2025 — Initial Termination Date (Current deadline for business combination)
- July 28, 2026 — Extended Termination Date (New potential deadline with extensions)
- 9 — Number of Monthly Extensions (Maximum number of one-month extensions available)
- $500 — New Monthly Extension Fee (Amount Sponsor must deposit for each extension)
- $5,000,001 — Net Tangible Assets Threshold (Minimum NTA required post-redemption under existing charter)
- 1,072,957 — New Units Redeemed (Number of units tendered for redemption at the Business Combination EGM)
- October 13, 2023 — Merger Agreement Date (Date Aimfinity entered into agreement with Docter Inc.)
- March 6, 2025 — F-4 Effective Date (Date SEC declared registration statement on Form F-4 effective)
- March 27, 2025 — Business Combination EGM Date (Date shareholders approved the Docter Business Combination)
- September 29, 2025 — Record Date (Date for determining shareholders entitled to vote at the Extraordinary Meeting)
Key Players & Entities
- Aimfinity Investment Corp. I (company) — Registrant and SPAC seeking extensions
- Docter Inc. (company) — Target company in the business combination
- SEC (regulator) — Securities and Exchange Commission, declared F-4 effective
- Nasdaq (regulator) — Stock exchange where PubCo aims to list
- Sponsor (company) — Party responsible for depositing extension fees
- $5,000,001 (dollar_amount) — Net tangible asset threshold for redemptions
- $500 (dollar_amount) — Cost per monthly extension fee
- 1,072,957 (dollar_amount) — Number of New Units tendered for redemption at Business Combination EGM
- VStock Transfer, LLC (company) — Transfer agent for the Company
FAQ
What is Aimfinity Investment Corp. I (AIMTF) proposing in its DEF 14A filing?
Aimfinity Investment Corp. I (AIMTF) is proposing two key amendments to its charter: the Charter Amendment Proposal to extend the business combination deadline to July 28, 2026, and the NTA Requirement Amendment Proposal to eliminate the $5,000,001 net tangible asset redemption limitation.
Why does Aimfinity Investment Corp. I need to extend its business combination period?
Aimfinity Investment Corp. I needs to extend its business combination period to gain more time and flexibility to complete the Docter Business Combination, which currently has a deadline of October 28, 2025. The proposed extension would allow for up to nine additional one-month extensions, pushing the final deadline to July 28, 2026.
What is the significance of the NTA Requirement Amendment Proposal for AIMTF?
The NTA Requirement Amendment Proposal is significant because it seeks to remove the charter's limitation that prevents redemptions if the company's net tangible assets fall below $5,000,001. Eliminating this restriction provides additional flexibility to consummate the Docter Business Combination, regardless of the redemption amount.
What happens if Aimfinity Investment Corp. I's shareholders do not approve the Charter Amendment Proposal?
If Aimfinity Investment Corp. I's shareholders do not approve the Charter Amendment Proposal, and a business combination is not completed by October 28, 2025, the company will cease operations, redeem its public shares, and liquidate, returning funds from the Trust Account to public shareholders.
When is the Extraordinary General Meeting for Aimfinity Investment Corp. I shareholders?
The Extraordinary General Meeting for Aimfinity Investment Corp. I shareholders is scheduled for October 27, 2025, at 11:00 a.m. Eastern Time, both in person in Taiwan and virtually via teleconference.
How much does each monthly extension cost the Sponsor for Aimfinity Investment Corp. I?
For each new monthly extension, the Sponsor or its affiliates or designees must deposit $500 into Aimfinity Investment Corp. I's Trust Account. This fee is required for each of the up to nine potential one-month extensions.
What was the outcome of the Business Combination EGM held on March 27, 2025, for Aimfinity Investment Corp. I?
At the Business Combination EGM on March 27, 2025, Aimfinity Investment Corp. I's shareholders approved the Docter Business Combination and other related matters. In connection with this meeting, 1,072,957 New Units were tendered for redemption.
Can shareholders redeem their shares if they vote against the proposals for Aimfinity Investment Corp. I?
Yes, public shareholders of Aimfinity Investment Corp. I may elect to redeem all or a portion of their public shares for cash in connection with the Charter Amendment Proposal and the NTA Requirement Amendment Proposal, regardless of whether they vote for or against, or abstain from voting on, these proposals.
What is the current status of the Docter Business Combination for Aimfinity Investment Corp. I?
The registration statement on Form F-4 relating to the Docter Business Combination was declared effective by the SEC on March 6, 2025, and shareholders approved the combination on March 27, 2025. Aimfinity Investment Corp. I is currently working diligently with Docter Inc. to qualify for Nasdaq listing.
What are the trading symbols for Aimfinity Investment Corp. I's units and shares?
Aimfinity Investment Corp. I's units are traded on OTCID under the symbol 'AIMUF'. The New Units are listed on Nasdaq under 'AIMTF', and Class 1 redeemable warrants are listed on Nasdaq under 'AIMWF'. Public shareholders wishing to redeem should submit New Units (Symbol 'AIMBU', CUSIP G0135E 142).
Risk Factors
- Failure to Complete Business Combination by Termination Date [high — operational]: The Company must complete its business combination with Docter Inc. by October 28, 2025, or face liquidation. Shareholder approval of the Charter Amendment Proposal is critical to extend this deadline to July 28, 2026, through up to nine one-month extensions, each requiring a $500 deposit from the Sponsor. Failure to approve this amendment will result in the cessation of operations and redemption of public shares.
- Net Tangible Assets Threshold Limitation [medium — regulatory]: The existing charter prevents redemptions if net tangible assets fall below $5,000,001. The NTA Requirement Amendment Proposal seeks to eliminate this restriction. If not amended, significant redemptions could trigger this limitation, potentially hindering the business combination or leading to early liquidation if other conditions are not met.
- Sponsor Funding for Extensions [low — financial]: Each of the up to nine one-month extensions to the business combination deadline requires the Sponsor to deposit $500 into the Trust Account. While this amount is nominal, it signifies the Sponsor's ongoing commitment and financial capacity to support the extension period, which is crucial for closing the Docter Business Combination.
Industry Context
Aimfinity Investment Corp. I operates as a special purpose acquisition company (SPAC) in the financial services sector. The SPAC market is characterized by its reliance on identifying and merging with viable target companies within a specific timeframe. Recent market trends have seen increased scrutiny on SPACs, with a focus on the quality of target businesses and the terms of proposed business combinations. Regulatory changes and investor sentiment can significantly impact the success rate and timelines for SPAC mergers.
Regulatory Implications
The proposed charter amendments are subject to shareholder approval and aim to provide Aimfinity with the necessary flexibility to complete its business combination. Failure to secure shareholder approval for the Charter Amendment Proposal could trigger mandatory liquidation under SEC rules and Cayman Islands law. The NTA Requirement Amendment addresses potential redemption-related constraints, ensuring compliance and operational continuity.
What Investors Should Do
- Vote FOR the Charter Amendment Proposal
- Vote FOR the NTA Requirement Amendment Proposal
- Review the proxy statement carefully
Key Dates
- 2025-10-27: Extraordinary General Meeting — Shareholders will vote on proposals to extend the business combination deadline and amend NTA requirements, crucial for the Docter Inc. merger.
- 2025-10-28: Initial Termination Date — Current deadline to complete the business combination; failure to extend will lead to liquidation.
- 2026-07-28: Extended Termination Date — Potential new deadline to complete the business combination if Charter Amendment Proposal is approved and extensions are utilized.
- 2023-10-13: Merger Agreement Date — Date Aimfinity Investment Corp. I entered into the merger agreement with Docter Inc.
- 2025-03-06: F-4 Effective Date — SEC declared the registration statement for the Docter Business Combination effective.
- 2025-03-27: Business Combination EGM Date — Shareholders previously approved the Docter Business Combination, with 1,072,957 New Units redeemed.
Glossary
- Charter Amendment Proposal
- A proposal to amend the company's charter to extend the deadline for completing a business combination. (Essential for Aimfinity to have more time to finalize the merger with Docter Inc.)
- NTA Requirement Amendment Proposal
- A proposal to remove the restriction that prevents share redemptions if net tangible assets fall below $5,000,001. (Provides flexibility in managing redemptions and ensures the business combination can proceed even with lower net tangible assets.)
- Combination Period
- The timeframe within which the company must complete its initial business combination. (The current period expires on October 28, 2025, necessitating the proposed extension.)
- Sponsor
- The entity that initially purchased the company's founder shares and warrants, providing initial capital. (The Sponsor is required to fund the monthly extension fees to prolong the Combination Period.)
- Trust Account
- An account holding the proceeds from the company's initial public offering, to be used for the business combination or returned to shareholders upon liquidation. (The Sponsor deposits extension fees into this account, and it is the source for shareholder redemptions.)
- Net Tangible Assets (NTA)
- A company's total assets minus intangible assets and total liabilities. (A threshold for NTA is currently in place that could restrict redemptions, which the company seeks to amend.)
- New Units
- Units issued by Aimfinity Investment Corp. I, likely comprising shares and warrants. (1,072,957 New Units were redeemed by shareholders at the previous Business Combination EGM.)
Year-Over-Year Comparison
This filing is a proxy statement for an extraordinary general meeting, distinct from typical annual or quarterly financial reports. Therefore, direct year-over-year comparisons of financial metrics like revenue, net income, or margins are not applicable. The focus is on procedural matters and shareholder votes required to facilitate a pending business combination, rather than ongoing operational performance.
Filing Stats: 4,280 words · 17 min read · ~14 pages · Grade level 19.8 · Accepted 2025-10-14 17:21:50
Key Financial Figures
- $5,000,001 — s net tangible assets to be less than US$5,000,001 following such redemptions (such propos
- $500 — (the “Trust Account”) the $500 each time at the time of such deposit (
- $12.80 — the Trust Account will be approximately $12.80 per share, subject to the actual value
- $20 — Units as of the Record Date was $20.37, there is no assurances that you may
- $0.0001 — ass B ordinary shares, par value $0.0001 per share, of the Company, (the “
Filing Documents
- ea0259405-02.htm (DEF 14A) — 781KB
- 0001213900-25-098869.txt ( ) — 782KB
From the Filing
DEF 14A 1 ea0259405-02.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ SCHEDULE 14A ___________________________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   Filed by a Party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material under §240.14a -12 AIMFINITY INVESTMENT CORP. I (Name of Registrant as Specified In Its Charter) _____________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box):   No fee required.   Fee paid previously with preliminary materials.   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0 -11 .   Table of Contents AIMFINITY INVESTMENT CORP. I 221 W 9 th  St, PMB 235 Wilmington, Delaware 19801 NOTICE OF AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS IN LIEU OF AN ANNUAL GENERAL MEETING TO THE SHAREHOLDERS OF AIMFINITY INVESTMENT CORP. I: You are cordially invited to attend an extraordinary general meeting of shareholders in lieu of an annual general meeting (the “Extraordinary Meeting”) of Aimfinity Investment Corp. I (the “Company,” “AIMA,” “we,” “us” or “our”), an exempted company incorporated with limited liability under the laws of the Cayman Islands, to be held at 11:00 a.m. Eastern Time, at 3F., No. 25, Gongyuan Rd., Pingtung City, Pingtung County, Taiwan (R.O.C.), and virtually via teleconference on October 27, 2025, for which you must register in advance at: https://forms.cloud.microsoft/r/pMLPzcu46r , or at such other time, on such other date and at such other place to which the meeting may be postponed or adjourned. At the Extraordinary Meeting, the shareholders will consider and vote upon the following proposals: 1.        Proposal No. 1 — Charter Amendment Proposal  — To approve by way of a special resolution, to amend Articles 49.7 and 49.8 of the Company’s Fourth Amended and Restated Memorandum and Articles of Association (the “Existing Charter”), in accordance with the form attached as Annex A hereto (the “Annex A”, the “Charter Amendment”, and such proposal, the “Charter Amendment Proposal”), to provide that the Company has until October 28, 2025 to complete a business combination, and may, by resolutions of the Board if requested the Sponsor, without the need for further approval of the Company’s shareholders, elect to extend the Combination Period up to nine times, each by an additional one -month  extension, for a total of up to nine months to July 28, 2026. The full wording of the special resolution to approve the Charter Amendment Proposal is set out in Annex A hereto; and 2.        Proposal No. 2 — NTA Requirement Amendment Proposal  — To approve by way of a special resolution, to amend Articles 49.2, 49.4, 49.5, and 49.8 of the Existing Charter, to eliminate the limitation that the Company may not redeem the Company’s public shares in an amount that would cause the Company’s net tangible assets to be less than US$5,000,001 following such redemptions (such proposal, the “NTA Requirement Amendment Proposal” and, together with the Charter Amendment Proposal, collectively, the “Proposals”) (such amendment to the Existing Charter as set forth in Annex B is herein referred to as the “NTA Requirement Amendment”). The full wording of the special resolution to approve the NTA Requirement Amendment Proposal is set out in Annex B hereto; and 3.        Proposal No. 3 — Adjournment Proposal  — A proposal by ordinary resolution, to approve the adjournment of the Extraordinary Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the other Proposals or if we determine that additional time is necessary to effectuate the Charter Amendment (the “Adjour